Monopar Therapeutics Inc. (MNPR)
NASDAQ · Healthcare
Monopar Therapeutics Inc. Cash on Hand 2016–2025
Monopar Therapeutics Inc. annual/quarterly cash on hand history from 2016 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Monopar Therapeutics Inc. cash on hand for the quarter ending December 31, 2025 were 61.8M, a 34.96% increase year-over-year.
- Monopar Therapeutics Inc. cash on hand for 2025 were 61.8M, a 34.96% increase from 2024.
- Monopar Therapeutics Inc. cash on hand for 2024 were 45.8M, a 246.73% increase from 2019.
- Monopar Therapeutics Inc. cash on hand for 2019 were 13.2M, a 91.71% increase from 2018.
- Monopar Therapeutics Inc. cash on hand for 2018 were 6.9M.
Cash on Hand
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Monopar Therapeutics Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $62 |
| 2024 | $46 |
| 2019 | $13 |
| 2018 | $7 |
| 2017 | $9 |
| 2016 | $2 |
| Monopar Therapeutics Inc. Quarterly Cash on Hand (Millions of US $) | |
|---|---|
| 2025-12-31 | $62 |
| 2024-12-31 | $46 |
| 2019-12-31 | $13 |
| 2018-12-31 | $7 |
| 2017-12-31 | $9 |
| 2016-12-31 | $2 |
Monopar Therapeutics Inc. Cash on Hand — FAQ
Monopar Therapeutics Inc. (MNPR) cash on hand over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see MNPR's cash on hand history?
The chart and table above show Monopar Therapeutics Inc.'s cash on hand by year and by quarter, including the growth rate.